Concepedia

Maksim Yezhelyev

MY

7

Publications

511

Citations

7

H-Index

2003

Active since

Affiliations

Ludwig-Maximilians-Universität München(Current)

University of Regensburg

AstraZeneca (United Kingdom)

LMU Klinikum

Maksim Yezhelyev is an author at Ludwig-Maximilians-Universität München specializing in oncology, tumor biology, and cancer research.

Top concepts

Publications per year

2003–2007

7

Publications

7

Inhibition of Src Tyrosine Kinase as Treatment for Human Pancreatic Cancer Growing Orthotopically in Nude Mice

Maksim Yezhelyev, Gudrun E. Koehl, Markus Guba et al. · Clinical Cancer Research · 2004 · 134 citations · Full text

Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF

Markus Guba, Maksim Yezhelyev, Martin Eichhorn et al. · Blood · 2005 · 127 citations

Rapamycin-Induced Endothelial Cell Death and Tumor Vessel Thrombosis Potentiate Cytotoxic Therapy against Pancreatic Cancer

Christiane J. Bruns, Gudrun E. Koehl, Markus Guba et al. · Clinical Cancer Research · 2004 · 113 citations

Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer

Ivan Ischenko, Markus Guba, Maksim Yezhelyev et al. · Angiogenesis · 2007 · 48 citations

, , +10

Recombinant anti-EGFR immunotoxin 425(scFv)-ETA' demonstrates anti-tumor activity against disseminated human pancreatic cancer in nude mice

Daniela Bruell, Christiane J. Bruns, Maksim Yezhelyev et al. · International Journal of Molecular Medicine · 2005 · 46 citations

Rows per page

1–5 of 7